磷解
尿嘧啶
尿苷
胸苷磷酸化酶
核苷酸回收
生物化学
嘧啶代谢
嘧啶
嘌呤核苷磷酸化酶
酶
核苷
癌症研究
化学
生物
核苷酸
基因
核糖核酸
嘌呤
DNA
作者
Deliang Cao,Giuseppe Pizzorno
出处
期刊:Drugs of Today
[Prous Science]
日期:2004-01-01
卷期号:40 (5): 431-431
被引量:54
标识
DOI:10.1358/dot.2004.40.5.850491
摘要
Uridine phosphorylase (UPase) is an enzyme that can convert uridine to uracil. Upon the availability of substrates, UPase can also catalyze the formation of nucleosides from uracil or 5-fluorouracil (5-FU) and ribose-1-phosphate (Rib-1-P). UPase gene expression appears featured with the developmental regulation and strictly controlled at promoter level by oncogenes, tumor suppressor genes and cytokines. UPase activity is usually elevated in various tumor tissues, and this induction appears to confer 5-FU therapeutic advantage to cancer patients. UPase is the most important phosphorylase identified up to date in the regulation of uridine homeostasis, although thymidine phosphorylase (TPase) can utilize to a certain extent uridine as a substrate. The modulation of UPase activity by its specific inhibitors such as benzylacyclouridine or the disruption of this gene greatly affects uridine metabolism and pyrimidine nucleotide biosynthesis. UPase also plays an appreciable role in the activation of 5-FU and its prodrug 5'-deoxy-5-fluorouridine (5'DFUR)/capecitabine via anabolism of 5-FU through pyrimidine salvage pathway or the phosphorolysis of 5'DFUR into 5-FU. In this review, we discuss in detail the role of UPase in the regulation of uridine homeostasis and pyrimidine metabolism and in the activation of fluoropyrimidines. To address its potential in cancer treatment, we will also discuss the regulatory mechanisms of UPase gene expression and its induction in tumor tissues.
科研通智能强力驱动
Strongly Powered by AbleSci AI